Compared with other disease sites in the available PanCan TCGA studies, HGSOC had the third highest alteration frequency, surpassing that of invasive breast carcinoma, for which MYBL2 (encoding B-Myb) carries a clinically significant predictive value (Figure 1A) (4, 5). Here, MYBL2 is linked to invasive breast carcinoma.